萝莉社

(904) 244-0411 Education Research Community

Treats Adults

Luis G Ortega Paz, MD

Cardiologist

Additional languages:: Spanish

(904) 383-1011

Request appointment online

Research at a glance

Research activity

60 publications

67 citations

Why is this important?

Active clinical trials

Switching from Clopidogrel to Low-dose Prasugrel in Patients at Dual-risk Following Percutaneous Coronary Intervention: TAILOR-BLEED-2 study

Investigators: Dominick J Angiolillo, Luis G Ortega Paz
Status: Accepting Candidates
Ages: 18 Years - 99 Years
Sexes: All

The Bridging Antiplatelet Therapy with Cangrelor 2 (BRIDGE 2) Study: A Pilot Prospective Cohort, Pharmacodynamic Study of Tailored Cangrelor Bridging Dosing Regimens

Investigators: Dominick J Angiolillo, Luis G Ortega Paz
Status: Accepting Candidates
Ages: 18 Years - 99 Years
Sexes: All

My publications

60 publications

2017

Rationale and design of the Hunting for the off-target propertIes of Ticagrelor on Endothelial function and other Circulating biomarkers in Humans (HI-TECH) trial

American Heart Journal

2017

Bioresorbable scaffolds: should we stay simple or go complex?

Cardiovascular Diagnosis and Therapy

鈥�

2017

Endothelial function impairment in STEMI patients with out-of-hospital cardiac arrest under therapeutic hypothermia treatment

International Journal of Cardiology

2017

Impact of overlapping on 1-year clinical outcomes in patients undergoing everolimus-eluting bioresorbable scaffolds implantation in routine clinical practice: Insights from the European multicenter GHOST-EU registry

Catheterization and Cardiovascular Interventions

2017

Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development and internal validation of the PSP score

EuroIntervention